ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
-0.26%
Brent Oil
88.165
0.02%
Bitcoin
63,801.48
-1.06%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Novartis AG (NVS)

  7. Novartis AG (NVS) Noticias

NVS Novartis AG

97.44
-1.62 (-1.64%)
Fuera de horario
Última actualización: 15:20:33
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Novartis AG NVS NYSE Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-1.62 -1.64% 97.44 15:20:33
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
97.76 97.44 98.22 97.44 99.06
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
23/4/202406:25IHMARKETNEWSApple Loses Market Share in China, GM Surges in Pre-Market..
15/4/202413:00PRNUSNew Novartis Fabhalta® (iptacopan) data show clinically..
11/4/202406:00GLOBEArvinas Enters into a Transaction with Novartis, including a..
10/4/202406:13IHMARKETNEWSDelta Generates US$37 Million Profit in Q1, Google and Intel..
06/4/202415:16PRNUSNew Novartis data show early addition of twice-yearly*..
15/2/202415:15EDGAR2Form S-8 POS - Securities to be offered to employees in..
06/2/202415:52EDGAR2Form SC TO-C - Written communication relating to an issuer..
06/2/202405:14IHMARKETNEWSBoeing Faces Strike Threat, Palantir Up 18% After Recording..
05/2/202416:06EDGAR2Form SC TO-C - Written communication relating to an issuer..
02/2/202413:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202406:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202406:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202406:42EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
31/1/202406:38EDGAR2Form 20-F - Annual and transition report of foreign private..
31/1/202405:28IHMARKETNEWSWalmart’s Stock Split, Elon Musk’s Billion-Dollar Package..
22/1/202400:59DJNSandoz to Acquire Cimerli Business from Coherus for $170..
12/1/202405:10IHMARKETNEWSWall Street Highlights: DocuSign Acquisition Battle, Tesla..
11/1/202412:02DJNCytokinetics Shares Slide as Novartis Reportedly Shies Away..
08/1/202412:43DJNCytokinetics Shares Jump 16% After WSJ Report of Novartis..
08/1/202409:41DJNNovartis on Track for Record High Close -- Data Talk
08/1/202405:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202401:01DJNNovartis's Scemblix Drug Meets Main Goals in Late-Stage..
05/1/202409:15DJNNovartis to Make Pluvicto Radioligand Therapy at..
02/1/202406:46DJNVoyager Therapeutics Shares Leap Premarket on Novartis..
11/12/202305:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202301:02DJNNovartis Drug Meets Primary Goal in Late-Stage Study for..
10/12/202318:39PRNUSNovartis presents new 48-week results from Phase III..
06/12/202304:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
05/12/202323:18PRNUSNovartis receives FDA approval for Fabhalta® (iptacopan),..
05/12/202305:25IHMARKETNEWSMoody’s Reassesses China, GitLab Exceeds Estimates, Twilio..
29/11/202305:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
28/11/202314:08DJNFDA Looking Into All Approved CAR T Therapies on Risk of..
28/11/202305:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202301:12DJNNovartis Raises Mid-Term Sales Growth Targets
13/11/202308:16DJNLegend Biotech Subsidiary in License Agreement With Novartis
01/11/202307:45IHNWGet Ready for Next Generation of Diabetes, Weight-Management..
01/11/202301:43DJNNovartis Skin Treatment Drug Cosentyx Gets US FDA Approval
30/10/202305:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202302:07DJNNovartis to Seek US Accelerated Approval of Atrasentan After..
27/10/202300:45DJNNovartis Says FDA Deems Pluvicto Shortage Resolved, Supply..
24/10/202306:22IHMARKETNEWSTuesday’s Wall Street Highlights: Coinbase, Intel, Redfin,..
24/10/202305:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202302:32DJNNovartis Raises Earnings Guidance Again After Key Drugs..
24/10/202300:48DJNNovartis Raises Earnings Guidance After Key Drugs Boost..
06/10/202316:11DJNNovartis Gets FDA Approval IV Formulation of Cosentyx
04/10/202305:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202304:17DJNNovartis Spinoff Sandoz Group Valued at $11.2 Billion in..
02/10/202305:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202301:10DJNNovartis Says Kidney Drug Phase 3 Trial Reaches Positive..
26/9/202301:03DJNNovartis's Sandoz to Commercialize Multiple Sclerosis..

Su Consulta Reciente

NYSE
NVS
Novartis
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados